Lactate Dehydrogenase B delactylation promotes gastric cancer metastasis via enhancing glutathione-mediated resistance to ferroptosis

Brisson L, Banski P, Sboarina M, Dethier C, Danhier P, Fontenille MJ, et al. Lactate dehydrogenase B controls lysosome activity and autophagy in cancer. Cancer Cell. 2016;30:418–31. https://doi.org/10.1016/j.ccell.2016.08.005.

Google Scholar 

Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9. https://doi.org/10.1038/nature13480

Chen Z, Fan J, Chen X, Yang K, Wang K. Oxidative stress and redox signaling in gastric cancer: from mechanisms to therapeutic implications. Antioxidants. 2025. https://doi.org/10.3390/antiox14030258.

Google Scholar 

Deng H, Zhao L, Ge H, Gao Y, Fu Y, Lin Y, et al. Ubiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancer. Nat Commun. 2025;16:2597. https://doi.org/10.1038/s41467-025-57906-3.

Google Scholar 

Dong Z, Yuan Z, Jin T, Gao C, Wang X, Xu F. Lactate at the crossroads of tumor metabolism and immune escape: a new frontier in cancer therapy. J Transl Med. 2025;23:1239. https://doi.org/10.1186/s12967-025-07272-x.

Google Scholar 

Frank AC, Raue R, Fuhrmann DC, Sirait-Fischer E, Reuse C, Weigert A, et al. Lactate dehydrogenase B regulates macrophage metabolism in the tumor microenvironment. Theranostics. 2021;11:7570–88. https://doi.org/10.7150/thno.58380.

Google Scholar 

Ge H, Malsiu F, Gao Y, Losmanova T, Blank F, Ott J, et al. Inhibition of LDHB suppresses the metastatic potential of lung cancer by reducing mitochondrial GSH catabolism. Cancer Lett. 2024;611:217353. https://doi.org/10.1016/j.canlet.2024.217353.

Google Scholar 

Gyorffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation (Camb). 2024;5:100625. https://doi.org/10.1016/j.xinn.2024.100625.

Google Scholar 

He Y, Song T, Ning J, Wang Z, Yin Z, Jiang P, et al. Lactylation in cancer: mechanisms in tumour biology and therapeutic potentials. Clin Transl Med. 2024;14:e70070. https://doi.org/10.1002/ctm2.70070.

Google Scholar 

Hong W, Zeng X, Wang H, Tan X, Tian Y, Hu H, et al. PGC-1α loss promotes mitochondrial protein lactylation in acetaminophen-induced liver injury via the LDHB-lactate axis. Pharmacol Res. 2024;205:107228. https://doi.org/10.1016/j.phrs.2024.107228.

Google Scholar 

Hu XT, Wu XF, Xu JY, Xu X. Lactate-mediated lactylation in human health and diseases: Progress and remaining challenges. J Adv Res. 2024b. https://doi.org/10.1016/j.jare.2024.11.010.

Google Scholar 

Hu X, Huang Z, Li L. LDHB Mediates Histone Lactylation to Activate PD-L1 and Promote Ovarian Cancer Immune Escape. Cancer Invest. 2024a:1-10https://doi.org/10.1080/07357907.2024.2430283

Leong T, Smithers BM, Michael M, Haustermans K, Wong R, Gebski V, et al. Preoperative chemoradiotherapy for resectable gastric cancer. N Engl J Med. 2024;391:1810–21. https://doi.org/10.1056/NEJMoa2405195.

Google Scholar 

Li Y, Liu J, Wu S, Xiao J, Zhang Z. Ferroptosis: opening up potential targets for gastric cancer treatment. Mol Cell Biochem. 2024;479:2863–74. https://doi.org/10.1007/s11010-023-04886-x.

Google Scholar 

Lin XM, Li S, Zhou C, Li RZ, Wang H, Luo W, et al. Cisplatin induces chemoresistance through the PTGS2-mediated anti-apoptosis in gastric cancer. Int J Biochem Cell Biol. 2019;116:105610. https://doi.org/10.1016/j.biocel.2019.105610.

Google Scholar 

Liu W, Chakraborty B, Safi R, Kazmin D, Chang CY, McDonnell DP. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat Commun. 2021;12:5103. https://doi.org/10.1038/s41467-021-25354-4.

Google Scholar 

Liu X, Zhuang L, Gan B. Disulfidptosis: disulfide stress-induced cell death. Trends Cell Biol. 2024;34:327–37. https://doi.org/10.1016/j.tcb.2023.07.009.

Google Scholar 

Lv M, Huang Y, Chen Y, Ding K. Lactylation modification in cancer: mechanisms, functions, and therapeutic strategies. Exp Hematol Oncol. 2025;14:32. https://doi.org/10.1186/s40164-025-00622-x.

Google Scholar 

Ni X, Lu CP, Xu GQ, Ma JJ. Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy. Acta Pharmacol Sin. 2024;45:1533–55. https://doi.org/10.1038/s41401-024-01264-1.

Google Scholar 

Pouyssegur J, Marchiq I, Parks SK, Durivault J, Zdralevic M, Vucetic M. Warburg effect’ controls tumor growth, bacterial, viral infections and immunity - genetic deconstruction and therapeutic perspectives. Semin Cancer Biol. 2022;86:334–46. https://doi.org/10.1016/j.semcancer.2022.07.004.

Google Scholar 

Shukri AH, Lukinovic V, Charih F, Biggar KK. Unraveling the battle for lysine: a review of the competition among post-translational modifications. Biochim Biophys Acta Gene Regul Mech. 2023;1866:194990. https://doi.org/10.1016/j.bbagrm.2023.194990.

Google Scholar 

Sui Y, Shen Z, Wang Z, Feng J, Zhou G. Lactylation in cancer: metabolic mechanism and therapeutic strategies. Cell Death Discov. 2025;11:68. https://doi.org/10.1038/s41420-025-02349-4.

Google Scholar 

Wan J, Shi JH, Shi M, Huang H, Zhang Z, Li W, et al. Lactate dehydrogenase B facilitates disulfidptosis and exhaustion of tumour-infiltrating CD8(+) T cells. Nat Cell Biol. 2025;27:972–82. https://doi.org/10.1038/s41556-025-01673-2.

Google Scholar 

Wang W, Green M, Choi JE, Gijon M, Kennedy PD, Johnson JK, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569:270–4. https://doi.org/10.1038/s41586-019-1170-y.

Google Scholar 

Wu Z, Huang R, Yuan L. Crosstalk of intracellular post-translational modifications in cancer. Arch Biochem Biophys. 2019;676:108138. https://doi.org/10.1016/j.abb.2019.108138.

Google Scholar 

Yang Z, Zou S, Zhang Y, Zhang J, Zhang P, Xiao L, et al. ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis. Nat Commun. 2023;14:4193. https://doi.org/10.1038/s41467-023-39901-8.

Google Scholar 

Zdralevic M, Brand A, Di Ianni L, Dettmer K, Reinders J, Singer K, et al. Double genetic disruption of lactate dehydrogenases A and B is required to ablate the “Warburg effect” restricting tumor growth to oxidative metabolism. J Biol Chem. 2018;293:15947–61. https://doi.org/10.1074/jbc.RA118.004180.

Google Scholar 

Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575–80. https://doi.org/10.1038/s41586-019-1678-1.

Google Scholar 

Zhao L, Deng H, Zhang J, Zamboni N, Yang H, Gao Y, et al. Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer. Cell Death Differ. 2025;32:632–45. https://doi.org/10.1038/s41418-024-01427-x.

Google Scholar 

Zheng Y, Sun L, Guo J, Ma J. The crosstalk between ferroptosis and anti-tumor immunity in the tumor microenvironment: molecular mechanisms and therapeutic controversy. Cancer Commun. 2023;43:1071–96. https://doi.org/10.1002/cac2.12487.

Google Scholar 

Comments (0)

No login
gif